Vaxart, Inc.
VXRT· OTC
VXRTVaxart, Inc.
Filed Mar 20, 2025 · 10-K · 79 days after period end · 0001437749-25-008572
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021 |
|---|---|---|---|---|
| Revenue | $15.19M | $3.25M | $22.00K | $74.00K |
| Net Income | -$11.99M | -$17.38M | -$23.92M | -$20.76M |
| EPS Diluted | — | — |
Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR
| — |
| -$0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2024 · filed Mar 20, 2025 · 79 d after period end
